Taylor Swift’s Eras Tour concert film surpasses $100 million in ticket sales

Taylor Swift’s Eras Tour concert film surpasses 0 million in ticket sales


Taylor Swift: The Eros Tour motion picture advertising image

Taylor Swift’s Eras Tour live performance movie is by now a $100 million blockbuster — and it has not even hit theaters but.

AMC declared Thursday that global progress ticket income for the pop singer’s movie surpassed the jaw-dropping threshold this week.

“Taylor Swift: The Eras Tour” is established to strike the big monitor on Oct. 13 in far more than 100 international locations throughout the environment, distributed by AMC.

AMC claimed audience demand for the film has been exceedingly high because the movie was announced, shattering the theater chain’s U.S. file for the best ticket gross sales profits during a one working day.

Box business office analysts projected the film could rake in $100 million on its opening weekend, with some expecting the film to keep on being in theaters longer than its scheduled operate because of to the higher fascination.

The film will chronicle Swift’s expertise for the duration of her record-breaking Eras Tour.



Source

Supreme Court allows Trump to withhold  billion in foreign aid funding
World

Supreme Court allows Trump to withhold $4 billion in foreign aid funding

A person walks past the U.S. Supreme Court in Washington, D.C., U.S., April 21, 2025. Kevin Lamarque | Reuters The Supreme Court on Friday handed another win to the Trump administration by allowing it to withhold $4 billion in spending on foreign aid that was appropriated by Congress. A federal judge had previously ruled that the administration would have […]

Read More
Chinese stocks are on fire this year, drawing big interest from foreign and domestic investors
World

Chinese stocks are on fire this year, drawing big interest from foreign and domestic investors

When Hou Yujie isn’t convincing customers to rent traditional Chinese clothing for photos at the country’s famous Forbidden City, she and her friends are checking stocks. Hou recently put 10% of her money in the market. In just a few days, she earned one month’s salary — and she’s thrilled.  “Interest rates for bank deposits […]

Read More
U.S. pharma tariffs spare India’s generic drugmakers — but leave investors jittery
World

U.S. pharma tariffs spare India’s generic drugmakers — but leave investors jittery

MUMBAI, INDIA – MARCH 3: A technician works at a Cipla laboratory March 3, 2002 in Vikhrohi, Mumbai, India. Jean-marc Giboux | 3rd Party – Misc | Getty Images Stocks of leading Indian drugmakers fell on Friday, even though the 100% U.S. tariffs on branded and patented drug imports are unlikely to affect these companies. […]

Read More